Perrigo, Actavis, others say US states' generic drug antitrust claims are time-barred
MLex Summary: Perrigo, Actavis, Amneal, and other pharmaceutical companies filed a motion for judgment against US states’ antitrust claims over generic drug pricing, arguing that they were filed too late. “Plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article